Application potential of modulation of cyclooxygenase-2 activity: a cognitive approach

[1]Watson R., Preedy V.: Omega Fatty Acids in Brain and Neurological Health. 2nd Edition. Academic Press, Cambridge MA, 2019.Watson R. Preedy V. Omega Fatty Acids in Brain and Neurological Health. 2nd Edition Academic Press Cambridge MA 2019Search in Google Scholar

[2]Zivkovic A.M., Telis N., German J.B., Hammock B.D.: Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health. Calif. Agric., 2011; 65: 106–111.Zivkovic A.M. Telis N. German J.B. Hammock B.D. Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health Calif. Agric 2011 65 106 11110.3733/ca.v065n03p106Search in Google Scholar

[3]Hanna V.S., Hafez E.A.: Synopsis of arachidonic acid metabolism: A review. J. Adv. Res., 2018; 11: 23–32.Hanna V.S. Hafez E.A. Synopsis of arachidonic acid metabolism: A review J. Adv. Res 2018 11 23 3210.1016/j.jare.2018.03.005Search in Google Scholar

[4]Lowin T., Straub R.H.: Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis. Arthritis Res. Ther., 2015; 17: 226.Lowin T. Straub R.H. Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis Arthritis Res. Ther 2015 17 22610.1186/s13075-015-0743-xSearch in Google Scholar

[5]Burdan F., Chałas A., Szumiło J.: Cyclooxygenase and prostanoids: biological implications. Postępy Hig. Med. Dośw., 2006; 60: 129–141.Burdan F. Chałas A. Szumiło J. Cyclooxygenase and prostanoids: biological implications Postępy Hig. Med. Dośw 2006 60 129 141Search in Google Scholar

[6]Fonteh A.N., Wykle R.L.: Arachidonate Remodeling and Inflammation. Birkhäuser Basel, Basel 2004.Fonteh A.N. Wykle R.L. Arachidonate Remodeling and Inflammation Birkhäuser Basel, Basel 200410.1007/978-3-0348-7848-7Search in Google Scholar

[7]Kudalkar S.N., Rouzera C.A., Marnett L.J.: The peroxidase and cyclooxygenase activity of prostaglandin H synthase. In: Heme Peroxdases, Eds: E. Ravenm, B. Dunford. The Royal Society of Chemistry, London 2016, 245–271.Kudalkar S.N. Rouzera C.A. Marnett L.J. The peroxidase and cyclooxygenase activity of prostaglandin H synthase Peroxdases Heme Ravenm E. Dunford B. The Royal Society of Chemistry London 2016 245 27110.1039/9781782622628-00245Search in Google Scholar

[8]Strauss K.I.: Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. Brain Behav. Immun., 2008; 22: 285–298.Strauss K.I. Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain Brain Behav. Immun 2008 22 285 29810.1016/j.bbi.2007.09.011Search in Google Scholar

[9]Breder C., Dewitt D., Kraig R.P.: Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol., 1995; 355: 296–315.Breder C. Dewitt D. Kraig R.P. Characterization of inducible cyclooxygenase in rat brain J. Comp. Neurol 1995 355 296 31510.1002/cne.903550208Search in Google Scholar

[10]Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F.: Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron, 1993; 11: 371–386.Yamagata K. Andreasson K.I. Kaufmann W.E. Barnes C.A. Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids Neuron 1993 11 371 38610.1016/0896-6273(93)90192-TSearch in Google Scholar

[11]López D.E., Ballaz S.J.: The role of brain cyclooxygenase-2 (Cox-2) beyond neuroinflammation: Neuronal homeostasis in memory and anxiety. Mol. Neurobiol., 2020; 57: 5167–5176.López D.E. Ballaz S.J. The role of brain cyclooxygenase-2 (Cox-2) beyond neuroinflammation: Neuronal homeostasis in memory and anxiety Mol. Neurobiol 2020 57 5167 517610.1007/s12035-020-02087-x32860157Search in Google Scholar

[12]Sang N., Zhang J., Marcheselli V., Bazan N.G., Chen C.: Post-synaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J. Neurosci., 2005; 25: 9858–9870.Sang N. Zhang J. Marcheselli V. Bazan N.G. Chen C. Post-synaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor J. Neurosci 2005 25 9858 987010.1523/JNEUROSCI.2392-05.2005672555916251433Search in Google Scholar

[13]Rouzer C.A., Marnett L.J.: Cyclooxygenases: Structural and functional insights. J. Lipid Res., 2009; 50: S29–S34.Rouzer C.A. Marnett L.J. Cyclooxygenases: Structural and functional insights J. Lipid Res 2009 50 S29 S3410.1194/jlr.R800042-JLR200Search in Google Scholar

[14]Smith W.L., Langenbach R.: Why there are two cyclooxygenase isozymes. J. Clin. Invest., 2001; 107: 1491–1495.Smith W.L. Langenbach R. Why there are two cyclooxygenase isozymes J. Clin. Invest 2001 107 1491 149510.1172/JCI13271Search in Google Scholar

[15]Blobaum A.L., Marnett L.J.: Structural and functional basis of cyclooxygenase inhibition. J. Med. Chem., 2007; 50: 1425–1441.Blobaum A.L. Marnett L.J. Structural and functional basis of cyclooxygenase inhibition J. Med. Chem 2007 50 1425 144110.1021/jm0613166Search in Google Scholar

[16]Vecchio A.J., Malkowski M.G.: The structure of NS-398 bound to cyclooxygenase-2. J. Struct. Biol., 2011; 176: 254–258.Vecchio A.J. Malkowski M.G. The structure of NS-398 bound to cyclooxygenase-2 J. Struct. Biol 2011 176 254 25810.1016/j.jsb.2011.07.019Search in Google Scholar

[17]Müller N.: COX-2 inhibitors, aspirin, and other potential anti-inflammatory treatments for psychiatric disorders. Front. Psychiatry, 2019; 10: 375.Müller N. COX-2 inhibitors, aspirin, and other potential anti-inflammatory treatments for psychiatric disorders Front. Psychiatry 2019 10 37510.3389/fpsyt.2019.00375Search in Google Scholar

[18]Dinchuk J.E., Car B.D., Focht R.J., Johnston J.J., Jaffee B.D., Covington M.B., Contel N.R., Eng V.M., Collins R.J., Czerniak P.M., et al.: Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature, 1995; 378: 406–409.Dinchuk J.E. Car B.D. Focht R.J. Johnston J.J. Jaffee B.D. Covington M.B. Contel N.R. Eng V.M. Collins R.J. Czerniak P.M. et al Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II Nature 1995 378 406 40910.1038/378406a0Search in Google Scholar

[19]Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., Mahler J.F., Lee C.A., Goulding E.H., Kluckman K.D., et al.: Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell, 1995; 83: 483–492.Langenbach R. Morham S.G. Tiano H.F. Loftin C.D. Ghanayem B.I. Chulada P.C. Mahler J.F. Lee C.A. Goulding E.H. Kluckman K.D. et al Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 1995 83 483 49210.1016/0092-8674(95)90126-4Search in Google Scholar

[20]Lim H., Paria B.C., Das S.K., Dinchuk J.E., Langenbach R., Trzaskos J.M., Dey S.K.: Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell, 1997; 91: 197–208.Lim H. Paria B.C. Das S.K. Dinchuk J.E. Langenbach R. Trzaskos J.M. Dey S.K. Multiple female reproductive failures in cyclooxygenase 2-deficient mice Cell 1997 91 197 20810.1016/S0092-8674(00)80402-XSearch in Google Scholar

[21]Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., Mahler J.F., Kluckman K.D., Ledford A., Lee C.A., Smithies O.: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell, 1995; 83: 473–482.Morham S.G. Langenbach R. Loftin C.D. Tiano H.F. Vouloumanos N. Jennette J.C. Mahler J.F. Kluckman K.D. Ledford A. Lee C.A. Smithies O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse Cell 1995 83 473 48210.1016/0092-8674(95)90125-6Search in Google Scholar

[22]Teather L.A., Packard M.G., Bazan N.G.: Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation. Learn. Mem., 2002; 9: 41–47.Teather L.A. Packard M.G. Bazan N.G. Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation Learn. Mem 2002 9 41 4710.1101/lm.4360215592611917005Search in Google Scholar

[23]Stachowicz K., Bobula B., Tokarski K.: NS398, a cyclooxygenase-2 inhibitor, reverses memory performance disrupted by imipramine in C57Bl/6J mice. Brain Res., 2020; 1734: 146741.Stachowicz K. Bobula B. Tokarski K. NS398, a cyclooxygenase-2 inhibitor, reverses memory performance disrupted by imipramine in C57Bl/6J mice Brain Res 2020 1734 14674110.1016/j.brainres.2020.146741Search in Google Scholar

[24]Stachowicz K.: Behavioral consequences of the co-administration of MTEP and the COX-2 inhibitor, NS398 in mice. Part 1. Behav. Brain Res., 2019; 370: 111961.Stachowicz K. Behavioral consequences of the co-administration of MTEP and the COX-2 inhibitor, NS398 in mice Part 1. Behav. Brain Res 2019 370 11196110.1016/j.bbr.2019.111961Search in Google Scholar

[25]Harrison F.E., Hosseini A.H., McDonald M.P.: Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory task. Behav. Brain Res., 2009; 198: 247–251.Harrison F.E. Hosseini A.H. McDonald M.P. Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory task Behav. Brain Res 2009 198 247 25110.1016/j.bbr.2008.10.015Search in Google Scholar

[26]Jerusalinsky D., Fin C., Quillfeld J.A., Ferreiara M.B., Schmitz P.K., Da Silva R.C., Walz R., Bazan N.G., Medina J.H., Izquierdo I.: Effect of antagonists of platelet-activating factor receptors on memory of inhibitory avoidance in rats. Behav. Neural Biol., 1994; 62: 1–3.Jerusalinsky D. Fin C. Quillfeld J.A. Ferreiara M.B. Schmitz P.K. Da Silva R.C. Walz R. Bazan N.G. Medina J.H. Izquierdo I. Effect of antagonists of platelet-activating factor receptors on memory of inhibitory avoidance in rats Behav. Neural Biol 1994 62 1 310.1016/S0163-1047(05)80052-4Search in Google Scholar

[27]Loza A.M., Elias V., Wong C.P., Ho E., Bermudez M., Magnusson K.R.: Effects of ibuprofen on cognition and NMDA receptor subunit expression across aging. Neuroscience, 2017; 344: 276–292.Loza A.M. Elias V. Wong C.P. Ho E. Bermudez M. Magnusson K.R. Effects of ibuprofen on cognition and NMDA receptor subunit expression across aging Neuroscience 2017 344 276 29210.1016/j.neuroscience.2016.12.041530364728057539Search in Google Scholar

[28]Stark D.T., Bazan N.G.: Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection. J. Neurosci., 2011; 31: 13710–13721.Stark D.T. Bazan N.G. Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection J. Neurosci 2011 31 13710 1372110.1523/JNEUROSCI.3544-11.2011319723421957234Search in Google Scholar

[29]Packard M.G., Teather L.A.: Double dissociation of hippocampal and dorsal-striatal memory systems by post-training intracerebral injections of 2-amino-5-phosphonopentanoic acid. Behav. Neuro-sci., 1997; 111: 545–551.Packard M.G. Teather L.A. Double dissociation of hippocampal and dorsal-striatal memory systems by post-training intracerebral injections of 2-amino-5-phosphonopentanoic acid Behav. Neuro-sci 1997 111 545 55110.1037/0735-7044.111.3.543Search in Google Scholar

[30]Stachowicz K., Sowa-Kućma M., Pańczyszyn-Trzewik P., Misztak P., Marciniak M., Bobula B., Tokarski K.: Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 2. Neurosci. Lett., 2021; 741: 135435.Stachowicz K. Sowa-Kućma M. Pańczyszyn-Trzewik P. Misztak P. Marciniak M. Bobula B. Tokarski K. Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice Part 2. Neurosci. Lett 2021 741 13543510.1016/j.neulet.2020.13543533171212Search in Google Scholar

[31]Cowley T.R., Fahey B., O’Mara S.M.: COX-2, but not COX-1, activity is necessary for the induction of perforant path long-term potentiation and spatial learning in vivo. Eur. J. Neurosci., 2008; 27: 2999–3008.Cowley T.R. Fahey B. O’Mara S.M. COX-2, but not COX-1, activity is necessary for the induction of perforant path long-term potentiation and spatial learning in vivo Eur. J. Neurosci 2008 27 2999 300810.1111/j.1460-9568.2008.06251.x18540883Search in Google Scholar

[32]Chen C., Magee J.C., Bazan N.G.: Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol., 2002; 87: 2851–2857.Chen C. Magee J.C. Bazan N.G. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity J. Neurophysiol 2002 87 2851 285710.1152/jn.2002.87.6.285112037188Search in Google Scholar

[33]Wong C.T., Bestard-Lorigados I., Crawford D.A.: Autism-related behaviors in the cyclooxygenase-2-deficient mouse model. Genes Brain Behav., 2019; 18: e12506.Wong C.T. Bestard-Lorigados I. Crawford D.A. Autism-related behaviors in the cyclooxygenase-2-deficient mouse model Genes Brain Behav 2019 18 e1250610.1111/gbb.1250630027581Search in Google Scholar

[34]Li H.L., Huang B.S., Vishwasrao H., Sutedja N., Chen W., Jin I., Hawkins R.D., Bailey C.H., Kandel E.R.: Dscam mediates trans-synaptic interactions for remodeling of glutamate receptors in Aplysia during de novo and learning-related synapse formation. Neuron, 2009; 61: 527–540.Li H.L. Huang B.S. Vishwasrao H. Sutedja N. Chen W. Jin I. Hawkins R.D. Bailey C.H. Kandel E.R. Dscam mediates trans-synaptic interactions for remodeling of glutamate receptors in Aplysia during de novo and learning-related synapse formation Neuron 2009 61 527 54010.1016/j.neuron.2009.01.010Search in Google Scholar

[35]Stachowicz K.: The role of DSCAM in the regulation of synaptic plasticity: Possible involvement in neuropsychiatric disorders. Acta Neurobiol. Exp., 2018; 78: 201–219.Stachowicz K. The role of DSCAM in the regulation of synaptic plasticity: Possible involvement in neuropsychiatric disorders Acta Neurobiol. Exp 2018 78 201 21910.21307/ane-2018-019Search in Google Scholar

[36]Neuss H., Huang X., Hetfeld B.K., Deva R., Henklein P., Nigam S., Mall J.W., Schwenk W., Dubiel W.: The ubiquitin- and protea-some-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibs. J. Mol. Med., 2007; 85: 961–970.Neuss H. Huang X. Hetfeld B.K. Deva R. Henklein P. Nigam S. Mall J.W. Schwenk W. Dubiel W. The ubiquitin- and protea-some-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibs J. Mol. Med 2007 85 961 97010.1007/s00109-007-0197-ySearch in Google Scholar

[37]Head E., Lott I.T., Patterson D., Doran E., Haier R.J.: Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: Targets for nonpharmacological intervention. J. Alzheimers Dis., 2007; 11: 61–76.Head E. Lott I.T. Patterson D. Doran E. Haier R.J. Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: Targets for nonpharmacological intervention J. Alzheimers Dis 2007 11 61 7610.3233/JAD-2007-11110Search in Google Scholar

[38]Jia Y.L., Jing L.J., Li J.Y., Lu J.J., Han R., Wang S.Y., Peng T., Jia Y.J.: Expression and significance of DSCAM in the cerebral cortex of APP transgenic mice. Neurosci. Lett., 2011; 491: 153–157.Jia Y.L. Jing L.J. Li J.Y. Lu J.J. Han R. Wang S.Y. Peng T. Jia Y.J. Expression and significance of DSCAM in the cerebral cortex of APP transgenic mice Neurosci. Lett 2011 491 153 15710.1016/j.neulet.2011.01.028Search in Google Scholar

[39]Cillero-Pastor B., Caramés B., Lires-Deán M., Vaamonde-García C., Blanco F.J, López-Armada M.J.: Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheumat., 2008; 58: 2409–2419.Cillero-Pastor B. Caramés B. Lires-Deán M. Vaamonde-García C. Blanco F.J López-Armada M.J. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes Arthritis Rheumat 2008 58 2409 241910.1002/art.23644Search in Google Scholar

[40]Kubis A.M., Janusz M.: Alzheimer disease: New prospects in therapy and applied experimental models. Postępy Hig. Med. Dośw., 2008; 62: 372–392.Kubis A.M. Janusz M. Alzheimer disease: New prospects in therapy and applied experimental models Postępy Hig. Med. Dośw 2008 62 372 392Search in Google Scholar

[41]Hoozemans J.J., Rozemuller A.J., Janssen I., De Groot C.J., Veerhuis R., Eikelenboom P.: Cyclooxygenase expression in microglia and neurons in Alzheimer disease and control brain. Acta Neuropathol., 2001; 101: 2–8.Hoozemans J.J. Rozemuller A.J. Janssen I. De Groot C.J. Veerhuis R. Eikelenboom P. Cyclooxygenase expression in microglia and neurons in Alzheimer disease and control brain Acta Neuropathol 2001 101 2 810.1007/s004010000251Search in Google Scholar

[42]Yermakova A.V., O’Banion M.K.: Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer disease. Neurobiol. Aging, 2001; 22: 823–836.Yermakova A.V. O’Banion M.K. Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer disease Neurobiol. Aging 2001 22 823 83610.1016/S0197-4580(01)00303-7Search in Google Scholar

[43]Medeiros R., Figueiredo C.P., Pandolfo P., Duarte F.S., Prediger R.D., Passos G.F., Calixto J.B.: The role of TNF-α signaling pathway on COX-2 upregulation and cognitive decline induced by β-amyloid peptide. Behav. Brain Res., 2010; 209: 165–173.Medeiros R. Figueiredo C.P. Pandolfo P. Duarte F.S. Prediger R.D. Passos G.F. Calixto J.B. The role of TNF-α signaling pathway on COX-2 upregulation and cognitive decline induced by β-amyloid peptide Behav. Brain Res 2010 209 165 17310.1016/j.bbr.2010.01.04020122965Search in Google Scholar

[44]Strauss K.I., Marini A.M.: Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cel death. J. Neurotrauma, 2002; 19: 627–638.Strauss K.I. Marini A.M. Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cel death J. Neurotrauma 2002 19 627 63810.1089/089771502753754091145632212042097Search in Google Scholar

[45]Grishin A.V., Wang J., Potoka D.A., Hackam D.J., Upperman J.S., Boyle P., Zamora R., Ford H.R.: Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J. Immunol., 2006; 176: 580–588.Grishin A.V. Wang J. Potoka D.A. Hackam D.J. Upperman J.S. Boyle P. Zamora R. Ford H.R. Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway J. Immunol 2006 176 580 58810.4049/jimmunol.176.1.58016365453Search in Google Scholar

[46]Akter K., Lanza E.A., Martin S.A., Myronyuk N., Rua M., Raffa R.B.: Diabetes mellitus and Alzheimer disease: Shared pathology and treatment? Br. J. Clin. Pharmacol., 2011; 71: 365–376.Akter K. Lanza E.A. Martin S.A. Myronyuk N. Rua M. Raffa R.B. Diabetes mellitus and Alzheimer disease: Shared pathology and treatment? Br J. Clin. Pharmacol 2011 71 365 37610.1111/j.1365-2125.2010.03830.x304554521284695Search in Google Scholar

[47]Tabecka-Lonczyńska A., Mytych J., Solek P., Kulpa-Greszta M., Jasiewicz P., Sowa-Kućma M., Stachowicz K., Koziorowski M.: IGF-1 as selected growth factor multi-response to antidepressant-like substances activity in C57BL/6J mouse testis model. Acta Histochem., 2021; 123: 151685.Tabecka-Lonczyńska A. Mytych J. Solek P. Kulpa-Greszta M. Jasiewicz P. Sowa-Kućma M. Stachowicz K. Koziorowski M. IGF-1 as selected growth factor multi-response to antidepressant-like substances activity in C57BL/6J mouse testis model Acta Histochem 2021 123 15168510.1016/j.acthis.2021.15168533556704Search in Google Scholar

[48]Schaefer E.J., Bongard V., Beiser A.S., Lamon-Fava S., Robins S.J., Au R., Tucker K.L., Kyle D.J., Wilson P.W., Wolf P.A.: Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch. Neurol., 2006; 63: 1545–1550.Schaefer E.J. Bongard V. Beiser A.S. Lamon-Fava S. Robins S.J. Au R. Tucker K.L. Kyle D.J. Wilson P.W. Wolf P.A. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study Arch. Neurol 2006 63 1545 155010.1001/archneur.63.11.154517101822Search in Google Scholar